Biotech RadarJobs updated

COMPANY

Procept BioRobotics

HQ: San Jose, CA source · procept-biorobotics.com ↗

FDA-cleared device company

30 open jobs · last seen Oct 23, 2026 · 18 sources

Location: San Jose, CA · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Localized Prostate Cancer Benign Prostatic Hyperplasia Lower Urinary Tract Symptoms AQUABEAM System Aquablation Therapy Robotic Waterjet Treatment Aquablation

Since the raise (Oct 30, 2024): 30 of 30 open jobs were first seen after it.

30Open jobs$175.0MRaised (2 yrs)13Trials (company is sponsor)3FDA records (2 yrs)

Hiring

TitleLocation (from posting)Employer postedFirst seen
Aquablation Sales Representative - JapanJapanOct 23, 2026Oct 23, 2026
Senior Territory Manager- Omaha, NENebraskaOct 20, 2026Oct 9, 2026
Sr Staff / Principal Electrical EngineerCalifornia - San JoseOct 15, 2026Oct 15, 2026
Senior Electrical EngineerCalifornia - San JoseOct 15, 2026Oct 16, 2026
Staff Electrical EngineerCalifornia - San JoseOct 14, 2026Oct 15, 2026

See all 30 jobs

Timeline

  1. Board tracked Radar started tracking this company’s job board (30 open jobs at last check). source ↗
  2. Trial start Not phased (device or behavioral study): WATER IV PCa (AS Sub-study) source ↗
  3. FDA FDA 510(k) clearance: HYDROS Robotic System (HY1000);HYDROS Handpiece (HH1000);HYDROS TRUS Probe (HU1000) — K260723, Jul 9, 2026. Applicant at approval: Procept Biorobotics. source ↗
  4. FDA FDA 510(k) clearance: AQUABEAM Robotic System — K253211, Jun 23, 2026. Applicant at approval: Procept Biorobotics. source ↗
  5. FDA FDA 510(k) clearance: HYDROS Robotic System (HY1000); HYDROS Handpiece (HH1000); HYDROS TRUS Probe (HU1000) — K251082, Oct 10, 2025. Applicant at approval: Procept Biorobotics. source ↗
  6. Trial start Not phased (device or behavioral study): WATER IV Prostate Cancer source ↗
  7. Raise Follow-on offering: $175M (total, as published), announced Oct 30, 2024. Source: company release on GlobeNewswire. source ↗
  8. Trial start Not phased (device or behavioral study): PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic System source ↗
  9. Trial start Not phased (device or behavioral study): PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTs source ↗
  10. Trial start —: UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue source ↗
  11. Trial start Not phased (device or behavioral study): French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue source ↗
  12. Trial start —: Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue source ↗
  13. Trial start Not phased (device or behavioral study): Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue II source ↗
  14. Trial start Not phased (device or behavioral study): Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia III source ↗
  15. Trial start Not phased (device or behavioral study): Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia II source ↗
  16. Trial start Not phased (device or behavioral study): Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia source ↗
  17. Trial start Not phased (device or behavioral study): Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER) source ↗
  18. Trial start Not phased (device or behavioral study): AQUABEAM India Study for the Treatment of Benign Prostatic Hyperplasia source ↗

Upcoming milestones

Estimated primary completion per ClinicalTrials.gov. Dates move.

Open jobs 30

TitleLocation (from posting, not HQ)Employer postedFirst seenLevel
Aquablation Sales Representative - JapanJapanOct 23, 2026Oct 23, 2026Not stated
Senior Territory Manager- Omaha, NENebraskaOct 20, 2026Oct 9, 2026Mid
Sr Staff / Principal Electrical EngineerCalifornia - San JoseOct 15, 2026Oct 15, 2026Senior
Senior Electrical EngineerCalifornia - San JoseOct 15, 2026Oct 16, 2026Not stated
Staff Electrical EngineerCalifornia - San JoseOct 14, 2026Oct 15, 2026Senior
Senior Territory Manager - Allentown, PAPennsylvaniaOct 2, 2026Oct 9, 2026Senior
Clinical Specialist- Albany/ Syracuse, NYNew YorkOct 1, 2026Oct 9, 2026Mid
Senior Manufacturing Engineer, EquipmentCalifornia - San JoseSep 28, 2026Oct 9, 2026Senior
Clinical Specialist - Kentucky WestKentuckySep 23, 2026Oct 9, 2026Mid
Senior Regulatory Affairs Labeling SpecialistCalifornia - San JoseSep 23, 2026Oct 9, 2026Senior
Clinical Specialist - West VirginiaWest VirginiaSep 23, 2026Oct 9, 2026Mid
Vice President, Global Regulatory AffairsCalifornia - San JoseSep 23, 2026Oct 9, 2026Executive
SEC Reporting and Technical Accounting ManagerCalifornia - San JoseSep 23, 2026Oct 9, 2026Mid
Salesforce AdministratorCalifornia - San JoseSep 23, 2026Oct 9, 2026Mid
Manager, Equipment and AutomationCalifornia - San JoseSep 23, 2026Oct 9, 2026Senior
Clinical Specialist - Cleveland, OHOhioSep 23, 2026Oct 9, 2026Mid
Staff IT AI Implementation EngineerCalifornia - San JoseSep 23, 2026Oct 9, 2026Senior
Senior Territory Manager - Detroit MetroOhioSep 23, 2026Oct 9, 2026Senior
Associate Account ManagerUnited KingdomSep 23, 2026Oct 9, 2026Mid
Senior Territory Manager- LouisianaLouisianaSep 23, 2026Oct 9, 2026Senior
Senior Manager, Sales OperationsCalifornia - San JoseSep 23, 2026Oct 9, 2026Senior
Area Sales Manager- Southern New EnglandMassachusettsSep 23, 2026Oct 9, 2026Mid
Regional Business Director - Great LakesMichiganSep 23, 2026Oct 9, 2026Senior
Assembler IICalifornia - San JoseSep 23, 2026Oct 9, 2026Mid
Quality Control Inspector IICalifornia - San JoseSep 23, 2026Oct 9, 2026Mid
Territory Manager - Western New YorkNew YorkSep 23, 2026Oct 9, 2026Mid
Assembler IICalifornia - San JoseSep 23, 2026Oct 9, 2026Mid
Clinical Specialist - IndianapolisIndianaSep 23, 2026Oct 9, 2026Mid
EMEA Marketing Manager Aquablation Program DevelopmentUnited KingdomSep 23, 2026Oct 9, 2026Mid
Area Sales Manager, UKUnited KingdomSep 23, 2026Oct 9, 2026Mid

Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.

Funding

Raised: $175.0M. Last 2 years.

Clinical trials (lead sponsor) 13

RecordTitlePhaseStatusStartPrimary completion
NCT07650448WATER IV PCa (AS Sub-study)Not phased (device or behavioral study)Not yet recruiting2026-092028-12 (estimated)
NCT06651632WATER IV Prostate CancerNot phased (device or behavioral study)Active, not recruitingFeb 3, 20252027-07 (estimated)
NCT06051942PRCT001 Aquablation theraPy Outcomes in pRostate Cancer patienTsNot phased (device or behavioral study)Active, not recruitingNov 22, 20222026-07 (estimated)
NCT06054867PRCT002 PRostate Cancer Treatment With the AQUABEAM Robotic SystemNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Mar 11, 20242025-04 (estimated)
NCT02505919Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue (WATER)Not phased (device or behavioral study)CompletedOct 30, 2015Jul 14, 2017 (actual)
NCT03123250Waterjet Ablation Therapy for Endoscopic Resection of Prostate Tissue IINot phased (device or behavioral study)CompletedAug 14, 2017Mar 27, 2018 (actual)
NCT04658056UK Post-market Waterjet Ablation Therapy for Endoscopic Resection of Prostate TissueNot listedUnknown status (ClinicalTrials.gov)2021-012022-01 (estimated)
NCT04308070Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia IIINot phased (device or behavioral study)CompletedJul 18, 2017Mar 22, 2018 (actual)
NCT02974751Global Post-Market Registry Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate TissueNot listedUnknown status (ClinicalTrials.gov)Sep 5, 2017May 24, 2019 (actual)
NCT03191734French Aquablation Clinical Investigation Using Waterjet Ablation Therapy for Endoscopic Resection of Prostate TissueNot phased (device or behavioral study)CompletedSep 19, 2017Jul 2, 2018 (actual)
NCT03167294AQUABEAM India Study for the Treatment of Benign Prostatic HyperplasiaNot phased (device or behavioral study)CompletedDec 14, 2014Jun 30, 2016 (actual)
NCT03125863Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic HyperplasiaNot phased (device or behavioral study)CompletedAug 26, 2016Sep 3, 2016 (actual)
NCT03125889Acute Hemostasis Following the Use of the AQUABEAM® System for the Treatment of Benign Prostatic Hyperplasia IINot phased (device or behavioral study)CompletedApr 10, 2017Apr 18, 2017 (actual)

FDA records (last 2 years)

Connect

See your connections at Procept BioRobotics on LinkedIn (search by name, results not checked)

LinkedIn shows your 1st and 2nd-degree connections here from your own login, including who could introduce you. Radar doesn't see your connections.

LinkedIn page linked from the company's own site: source · seen 2026-10-12

Feedback